TITLE

Cardiovascular failure, inotropes and vasopressors

AUTHOR(S)
Benham-Hermetz, Julia; Lambert, Mark; Stephens, Robert C. M.
PUB. DATE
May 2012
SOURCE
British Journal of Hospital Medicine (17508460);May2012 Supplement, pC74
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article discusses cardiovascular failure, which occurs when tissue oxygen delivery is inadequate to meet tissue oxygen demand. It mentions the importance of using inotropes to increase myocardial contraction and cardiac output; and vasopressors to increase systematic vascular resistance. Definitions of key parameters in cardiovascular physiology are listed. The article also states that patients on inotropes and vasopressors need to be managed on a critical care unit.
ACCESSION #
75504774

 

Related Articles

  • Heart failure: Novel therapeutic approaches. Pate, C.; Deoghare, S. // Journal of Postgraduate Medicine;Apr-Jun2015, Vol. 61 Issue 2, p101 

    Heart failure (HF) is a complex clinical syndrome that can result from any structural or functional cardiac disorders that impairs the ability of the ventricle to fill with or eject blood. Despite effective medical interventions, mortality and morbidity remain substantial. There have been...

  • Anti-necrotic and cardioprotective effects of a cytosolic renin isoform under ischemia-related conditions. Wanka, Heike; Staar, Doreen; Lutze, Philipp; Peters, Barbara; Hildebrandt, Johanna; Beck, Tim; Bäumgen, Inga; Albers, Alexander; Krieg, Thomas; Zimmermann, Katrin; Sczodrok, Jaroslaw; Schäfer, Simon; Hoffmann, Sigrid; Peters, Jörg // Journal of Molecular Medicine;Jan2016, Vol. 94 Issue 1, p61 

    In the heart, secretory renin promotes hypertrophy, apoptosis, necrosis, fibrosis, and cardiac failure through angiotensin generation from angiotensinogen. Thus, inhibitors of the renin-angiotensin system are among the most potent drugs in the treatment of cardiac failure. Renin transcripts have...

  • Ischemic Colitis after Cardiac Surgery: Can We Foresee the Threat? Arif, Rawa; Farag, Mina; Zaradzki, Marcin; Reissfelder, Christoph; Pianka, Frank; Bruckner, Thomas; Kremer, Jamila; Franz, Maximilian; Ruhparwar, Arjang; Szabo, Gabor; Beller, Carsten J.; Karck, Matthias; Kallenbach, Klaus; Weymann, Alexander // PLoS ONE;12/15/2016, Vol. 11 Issue 12, p1 

    Introduction: Ischemic colitis (IC) remains a great threat after cardiac surgery with use of extracorporeal circulation. We aimed to identify predictive risk factors and influence of early catecholamine therapy for this disease. Methods: We prospectively collected and analyzed data of 224...

  • Pharmacological management of fluid overload. Goldstein, S.; Bagshaw, S.; Cecconi, M.; Okusa, M.; Wang, H.; Kellum, J.; Mythen, M.; Shaw, A. D. // BJA: The British Journal of Anaesthesia;Nov2014, Vol. 113 Issue 5, p756 

    Background Standard treatment practice for the hypotensive patient with poor tissue perfusion is rapid volume resuscitation; in some scenarios, such as septic shock, this is performed with targeted goal-directed endpoints within 6 h of presentation. As a result, patients often develop...

  • Sodium and Water Excretion in Heart Failure: Efficacy of Treatment Has Surpassed Knowledge of Pathophysiology. Francis, Gary S. // Annals of Internal Medicine;Aug86, Vol. 105 Issue 2, p272 

    Editorial. Discusses the vasoconstriction and sodium-retentive abnormalities of heart failure. Symptoms of a congestive heart failure; Therapeutic use of norepinephrine and vasopressin; Hemodynamic and neurohumoral abnormalities in patients with advanced congestive heart failure.

  • Novel Therapeutic Targets in Heart Failure: The Phospholipase Cβ1b-Shank3 Interface. Woodcock, Elizabeth A.; Grubb, David R. // Clinical Medicine Insights: Therapeutics;2015, Issue 7, p11 

    Inotropic agents are often used to improve the contractile performance of the failing myocardium, but this is often at a cost of increased myocardial ischemia and arrhythmia. Myocyte contractility depends on the release of Ca2+ from the sarcoplasmic reticulum, and this Ca2+ is subject to...

  • Rate Control with Ivabradine. Parakh, Neeraj; Bhargava, Balram // American Journal of Cardiovascular Drugs;2011, Vol. 11 Issue 1, p1 

    The importance of heart rate in human health and disease has been well known to clinicians for quite some time. Recent epidemiologic studies have further strengthened this concept. Modulation of heart rate by pharmacologic as well as non-pharmacologic means has affected cardiovascular mortality...

  • Use of Inotropic Agents in Patients with Advanced Heart Failure: Lessons from Recent Trials and Hopes for New Agents. Metra, Marco; Bettari, Luca; Carubelli, Valentina; Bugatti, Silvia; Dei Cas, Alessandra; Del Magro, Francesca; Lazzarini, Valentina; Lombardi, Carlo; Dei Cas, Livio // Drugs;2011, Vol. 71 Issue 5, p515 

    Abnormalities of cardiac function, with high intraventricular filling pressure and low cardiac output, play a central role in patients with heart failure. Agents with inotropic properties are potentially useful to correct these abnormalities. However, with the exception of digoxin, no inotropic...

  • Selective and Specific Inhibition of I with Ivabradine for the Treatment of Coronary Artery Disease or Heart Failure. Deedwania, Prakash // Drugs;2013, Vol. 73 Issue 14, p1569 

    Heart rate is an important contributor in the pathophysiology of both coronary artery disease (CAD) and heart failure (HF). Ivabradine is an anti-anginal and anti-ischaemic agent, which selectively and specifically inhibits the I current in the sino-atrial node and provides pure heart rate...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics